Literature DB >> 13092368

Studies in human malaria. XXXIV. Acquired resistance to pyrimethamine (daraprim) by the Chesson strain of plasmodium vivax.

T HERNANDEZ, A V MYATT, G R COATNEY, G M JEFFERY.   

Abstract

Entities:  

Keywords:  ANTIMALARIALS/effects; PLASMODIUM VIVAX

Mesh：

Substances：

Year:  1953        PMID： 13092368

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  6 in total

Review 1.  Resistance to therapies for infection by Plasmodium vivax.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

2.  Pyrimethamine resistance in Plasmodium vivax malaria.

Authors:  M D YOUNG; R W BURGESS
Journal:  Bull World Health Organ       Date:  1959       Impact factor: 9.408

3.  The development of pyrimethamine resistance by Plasmodium falciparum.

Authors:  R W BURGESS; M D YOUNG
Journal:  Bull World Health Organ       Date:  1959       Impact factor: 9.408

4.  Quantitative assessment of antimalarial activities from Malaysian Plasmodium falciparum isolates by modified in vitro microtechnique.

Authors:  A H Hoon; C K Lam; M J Wah
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

5.  Synthesis and antiplasmodial activity of purine-based C-nucleoside analogues.

Authors:  Kartikey Singh; Prince Joshi; Rohit Mahar; Pragati Baranwal; Sanjeev K Shukla; Renu Tripathi; Rama Pati Tripathi
Journal:  Medchemcomm       Date:  2018-05-29       Impact factor: 3.597

Review 6.  Antimalarial Drug Resistance: Literature Review and Activities and Findings of the ICEMR Network.

Authors:  Liwang Cui; Sungano Mharakurwa; Daouda Ndiaye; Pradipsinh K Rathod; Philip J Rosenthal
Journal:  Am J Trop Med Hyg       Date:  2015-08-10       Impact factor: 2.345
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.